NOT-EB-22-011: Notice of Extension of the Expiration Date of PAR-20-169, "National Centers for Biomedical Imaging and Bioengineering (NCBIB) (P41 Clinical Trials Optional)"

Notice of Extension of the Expiration Date of PAR-20-169, "National Centers for Biomedical Imaging and Bioengineering (NCBIB) (P41 Clinical Trials Optional)"

Notice Number:

NOT-EB-22-011

Key Dates

Release Date:

November 1, 2022

Related Announcements

PAR-20-169 National Centers for Biomedical Imaging and Bioengineering (NCBIB) (P41 Clinical Trials Optional)

Issued by

National Institute of Biomedical Imaging and Bioengineering (NIBIB)

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Purpose

The purpose of this Notice is to extend the expiration date of PAR-20-169, "National Centers for Biomedical Imaging and Bioengineering (NCBIB) (P41 Clinical Trials Optional)" by one application due date. PAR-20-169 will now expire on September 8, 2023.

The following section of PAR-20-169 has been modified to reflect the change:

Part 1. Overview

Key Dates

Currently Reads:

Expiration Date May 08, 2023

Modified to Read (change shown in bold italics):

Expiration Date September 08, 2023

All other aspects of this PAR-19-159 remain unchanged.

Inquiries

Please direct all inquiries to:

Behrouz Shabestari, PhD
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
Telephone: 301-451-6771
Email: [email protected]